Development of Molecular Diagnostic Innovation System in India: Role of Scientific Institutions
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The study attempts to examine the system-building activities of scientific institutions in developing the Molecular Diagnostic (MDs) Innovation System in India. Scientific Institutions are the precursor of any technological development with their capabilities in generating new ideas. MDs are advanced and accurate diagnostic technology with considerable scope to serve the diagnostic needs and requirements of the healthcare system. We adopted a System framework and analyzed the development of MDs in terms of the Technological Innovation System (TIS) functions, and the systematic challenges are assessed through the System Failure Framework (SFF). Based on the secondary and primary survey of prominent science base actors, the study finds that the role of government is crucial for facilitating technological development within a science base through the mobilization of resources. In India, the MDs technological development gained significant momentum over the last decade with the development of specialized human resources and dedicated research institutes. However, we do find that the innovative capabilities in attaining need-based TIS are sub-optimal owning to the specific diagnostic needs of highly burdened diseases in the society. The system analysis reveals that the TIS functions are underperforming because of the absence of a well-defined funding mechanism and goal-oriented targeted policy regime of the government. Since MDs have a transformative effect on the present healthcare system, we argue that the government has to address the system-based challenges and issues for developing a need-based technological innovation system for MDs in the country.
Abstract
The study attempts to examine the system-building activities of scientific institutions in developing the Molecular Diagnostic (MDs) Innovation System in India. Scientific Institutions are the precursor of any technological development with their capabilities in generating new ideas. MDs are advanced and accurate diagnostic technology with considerable scope to serve the diagnostic needs and requirements of the healthcare system. We adopted a System framework and analyzed the development of MDs in terms of the Technological Innovation System (TIS) functions, and the systematic challenges are assessed through the System Failure Framework (SFF). Based on the secondary and primary survey of prominent science base actors, the study finds that the role of government is crucial for facilitating technological development within a science base through the mobilization of resources. In India, the MDs technological development gained significant momentum over the last decade with the development of specialized human resources and dedicated research institutes. However, we do find that the innovative capabilities in attaining need-based TIS are sub-optimal owning to the specific diagnostic needs of highly burdened diseases in the society. The system analysis reveals that the TIS functions are underperforming because of the absence of a well-defined funding mechanism and goal-oriented targeted policy regime of the government. Since MDs have a transformative effect on the present healthcare system, we argue that the government has to address the system-based challenges and issues for developing a need-based technological innovation system for MDs in the country.
참고문헌 (15)
- "Introduction to Molecular Diagnostics: The Essentials of Diagnostics Series" (2013)[URL]
- Bergek, Jacobsson, "Legitimation and Development of Positive Externalities: Two key Processes in the Formation Phase of Technological Innovation Systems", Technology Analysis & Strategic Management, 20(5), pp.575~592 (2008)
- Kennedy, "The relationship between Science and Technology", Research Policy, 23, pp.477~486 (1994)
- Carlsson, "On the Nature, Function and Composition of Technological Systems", Journal of Evolutionary Economics, 1(2), pp.93~118 (1991)
- Constance, "The future of Molecular Diagnostics; Innovative Technologies Driving Market Opportunities in Personalized Medicine" (2010), Business Insights Ltd
- Garcia, "Science and Technology and their role in Human Health in Developing Countries", Mem Inst Oswaldo Cruz, Rio de Janeiro, 95(1), pp.5~7 (2000)
- Guglielmi, "Researchers are scrambling to find new ways to diagnose the coronavirus and churn out millions of tests a week — a key step in returning to relative normality", Nature, 583, pp.506~509 (2020)
- Mierlo, Arkesteijn, "Enhancing the Reflexivity of System Innovation Projects with System Analyses", American Journal of Evaluation, 31(2), pp.143~161 (2010)
- Musiolik, "Networks and Network Resources in Technological Innovation Systems: Towards a Conceptual Framework for system building", Technological Forecasting and Social Change, 79(6), pp.1032~1048 (2012)
- OECD, "National Innovation Systems" (1997)
- Poste, "Molecular Diagnostics: A Powerful New Component of the Healthcare Value Chain", Expert Rev. Mol. Diag, 1(1) (2001)
- Singh, "n-Vitro Diagnostics (IVDs) Innovations for Resource-Poor Settings: The Indian Experience", African Journal of Science Technology Innovation and Development, 9(5), pp.617~636 (2017)
- Woolthuis, "A System Failure Framework for Innovation Policy Design", Technovation, 25(6), pp.609~619 (2005)
- "Advisory: Newer Additional Strategies for COVID-19 Testing" (2020)[URL]
- "Role of evidence-based &well-researched guidance is vital in defeating the pandemic" (2021)[URL]